Developing non-electrical basal and bolus drug delivery technologies and devices for large and small molecules. The first product is a basal-bolus insulin pump for the Type II Diabetes market.
Location: United States, New Jersey, Parsippany-Troy Hills
Total raised: $250M
Investors 5
Date | Name | Website |
- | Phoenix Ve... | phoenix-vp... |
- | CRG | crglp.com |
- | Kaiser Per... | kpventures... |
11.03.2021 | Abingworth... | abingworth... |
- | Agate Medi... | agate-inve... |
Funding Rounds 2
Date | Series | Amount | Investors |
07.06.2013 | - | $100M | - |
12.09.2011 | Series C | $150M | - |
Mentions in press and media 15
Date | Title | Description | Source |
26.03.2015 | Diabetes: Valeritas delays $75m IPO | Valeritas today postponed its planned initial public offering, which at the midpoint was slated to f... | massdevice... |
12.03.2015 | Valeritas sets terms for $75m IPO | Medtech Wall Street news... | Diabetes: Valeritas sets terms for $75m IPO March 10, 2015 by Brad Perriello Valeritas yesterday se... | massdevice... |
10.03.2015 | Diabetes: Valeritas sets terms for $75m IPO | Valeritas yesterday set the terms for its forthcoming initial public offering, saying it plans to pu... | massdevice... |
13.02.2015 | Diabetes: Valeritas registers $90m IPO | Valeritas yesterday registered for an initial public offering worth up to $90 million for its V-Go i... | massdevice... |
07.07.2014 | Type 2 insulin pump maker Valeritas raising large equity rou... | Valeritas raised $100 million in structured debt financing in June 2013 to commercialize the V-Go, b... | medcitynew... |
16.10.2013 | Straight Talk About Diabetes: More Tools Needed | Preventative measures should actually include bariatric procedures, he added, noting, “The risk redu... | medcitynew... |
07.06.2013 | Valeritas Closes $100M Debt Financing with Capital Royalty | Valeritas, Bridgewater, N.J.-based insulin delivery device, closed a $100m structured debt financing... | finsmes.co... |
04.06.2013 | Diabetes: Valeritas lands $100M fund for insulin delivery sy... | Diabetes devices maker Valeritas announced today that it closed a structured debt financing with $10... | massdevice... |
09.07.2012 | B-to-c diabetes patient engagement company adds b-to-b capab... | As various healthcare stakeholders look for ways to engage patients in a bid to keep them healthy an... | medcitynew... |
12.09.2011 | Valeritas Announces $150M Series C | Welsh, Carson, Anderson and Stowe led the financing and assumes a controlling interest in Valerita... | vcnewsdail... |
Show more